Beckman Coulter Recalls CellMek SPS Sample Preparation System Due to Software Error
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Beckman Coulter, Inc. has issued a voluntary recall for 50 CellMek SPS Sample Preparation Systems due to a software glitch that could lead to incorrect patient diagnoses.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on February 18, 2026 and geographically references Worldwide. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, MedicalDevices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Beckman Coulter, Inc. has initiated a voluntary recall of the CellMek SPS Sample Preparation System due to a software error in version 2.3.90.0. The system, which is designed to automate staining, lysing, and cell washing, may dispense samples too close to or touching the bottom of tubes. This defect can dislodge fluid lines, cause sample loss or spillage, and render the instrument inoperable. Most critically, the error can lead to the unintentional removal of 60-100 microliters from the final sample, which may result in incorrect medical diagnoses or improper patient management.
Which Products Are Affected
The recall involves the following medical device equipment:
- Product Name: CellMek SPS Sample Preparation System
- Reference Number: REF: C44603
- Software Version: 2.3.90.0
- UDI-DI: 15099590750312
- Recall Number: Z-1235-2026
- Quantity: 50 units
The affected units were distributed in the U.S. states of Alabama, Illinois, Massachusetts, Missouri, Oregon, and Washington. International distribution includes Austria, Australia (VIC), Belgium, Canada (AB, ON), Switzerland, Germany, Spain, France, Great Britain, Mexico, Netherlands, and Slovakia.
What You Should Do
Beckman Coulter, Inc. notified customers of the issue via a formal letter sent on December 23, 2025. Users of the CellMek SPS Sample Preparation System should verify if their equipment is running software version 2.3.90.0 and follow the instructions provided in the firm's notification. For additional information, the recalling firm is located at 11800 Sw 147th Ave, Miami, FL 33196-2500.
Why This Matters
This recall is significant because the software defect can compromise the integrity of clinical samples. The resulting loss of sample volume poses a risk of incorrect diagnostic results, which could lead to inappropriate medical treatment or patient management decisions.
Source
Information provided by the FDA (Recall Event ID: 98207).
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category